| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049289438 |
| P356 | DOI | 10.2165/00002512-199506030-00003 |
| P698 | PubMed publication ID | 7542508 |
| P2093 | author name string | D Platt | |
| F Porzsolt | |||
| J Zeeh | |||
| P2860 | cites work | The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 |
| FUNCTIONAL EVALUATION: THE BARTHEL INDEX | Q28201591 | ||
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| Single-agent oral etoposide for elderly small cell lung cancer patients. | Q33395215 | ||
| Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium | Q34350640 | ||
| Variation in breast cancer surgery in Ontario. | Q34707830 | ||
| Changes in renal function with aging. Implications for treatment | Q35364174 | ||
| Minimising the side effects of cancer chemotherapy in senior patients | Q36167886 | ||
| Psychological effects of being offered choice of surgery for breast cancer | Q36886934 | ||
| Gerontology as oncology. Research on aging as the key to the understanding of cancer | Q37428950 | ||
| Cancer in the aged. An epidemiologic perspective on treatment issues | Q37428956 | ||
| Cancer in the elderly: why so badly treated? | Q37584913 | ||
| The ambiguous relation between aging and adverse drug reactions | Q37711723 | ||
| Instruments for the functional assessment of older patients | Q37914820 | ||
| Hepatic drug metabolism and aging | Q38018026 | ||
| Management of drug therapy in the elderly | Q38662035 | ||
| Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions | Q39627241 | ||
| Non-Hodgkin's malignant lymphomas in patients older than 80. 70 cases | Q39636816 | ||
| Patterns of care related to age of breast cancer patients | Q39771297 | ||
| Functional criteria for staging and treatment of hairy cell leukemia | Q70201451 | ||
| "Though much is taken": reflections on aging, health, and medical care | Q70476679 | ||
| Cancer treatment and age: patient perspectives | Q70508103 | ||
| Acute lymphoblastic leukemia--progress in children, less in adults | Q70513298 | ||
| Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death | Q70524864 | ||
| The Italian experience in the treatment of HCL. Italian Cooperative Group for HCL | Q70694511 | ||
| Goals of palliative cancer therapy | Q72068688 | ||
| Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology | Q72069849 | ||
| Approaches to palliation and its evaluation | Q72069855 | ||
| Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG) | Q72079279 | ||
| Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR) | Q72079286 | ||
| Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer | Q72742367 | ||
| Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period | Q72891398 | ||
| Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group | Q93501545 | ||
| Resuscitation in the elderly: a blessing or a curse? | Q93534417 | ||
| The Oregon priority-setting exercise: quality of life and public policy | Q94021761 | ||
| Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders | Q40385554 | ||
| Quality of life assessment in palliative care | Q40388565 | ||
| Palliative medicine today—a matter for concern | Q40484847 | ||
| Goals of palliative cancer therapy: scope of the problem | Q40484856 | ||
| Lessons learned from measuring health-related quality of life in oncology | Q40720847 | ||
| Multiple myeloma: a tailored therapy for elderly patients. | Q40903625 | ||
| Hodgkin's disease of the elderly. A different disease? | Q40903631 | ||
| The Patient Self-Determination Act and the future of advance directives | Q41140372 | ||
| Treatment of elderly patients with breast cancer | Q42816082 | ||
| A population-based study of functional status and social support networks of elderly patients newly diagnosed with cancer | Q43633669 | ||
| Does a small minority of elderly account for a majority of health care expenditures? A sixteen-year perspective | Q44116283 | ||
| Cancer control and the older person. Issues in treatment | Q44270660 | ||
| Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]. | Q44525523 | ||
| Women with lung cancer: impact on quality of life | Q44997792 | ||
| Primary dexamethasone treatment of multiple myeloma | Q45032592 | ||
| Medical care in the last twelve months of life: the relation between age, functional status, and medical care expenditures | Q45205680 | ||
| Informed consent, cancer, and truth in prognosis | Q46558108 | ||
| Effects of offering advance directives on medical treatments and costs | Q46636678 | ||
| Mastery of stress: psychosocial aspects | Q47615610 | ||
| The use and cost of health services prior to death: a comparison of the Medicare-only and the Medicare-Medicaid elderly populations | Q48647597 | ||
| Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study | Q50117137 | ||
| When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L. | Q51055531 | ||
| A population-based study of dementia in 85-year-olds. | Q52038432 | ||
| Conducting clinical research in geriatric populations. | Q52664973 | ||
| Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. | Q52882178 | ||
| The effect of age upon liver volume and apparent liver blood flow in healthy man. | Q53846028 | ||
| The role of hospitals in caring for people in the last year of their lives. | Q54422381 | ||
| The ethics of research in the elderly | Q57194874 | ||
| Lung cancer in the elderly | Q59504157 | ||
| Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study | Q59504239 | ||
| Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients | Q60152873 | ||
| Quality of life and patients with cancer: a comparative study of patient versus physician perceptions and its implications for cancer education | Q67570373 | ||
| Decision making during serious illness: what role do patients really want to play? | Q67580125 | ||
| Cancer pain relief and palliative care. Report of a WHO Expert Committee | Q67677822 | ||
| Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome | Q67899699 | ||
| Biology of cancer and aging | Q68032659 | ||
| [Therapy with cytostatic drugs in the elderly] | Q68039978 | ||
| Cardiac complications observed in elderly patients following 2'-deoxycoformycin therapy | Q68058481 | ||
| When should hairy cell leukaemia be treated? | Q68161168 | ||
| Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial | Q68184277 | ||
| Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus plus postoperative radiotherapy | Q68468166 | ||
| Acute lymphoblastic leukemia in the elderly | Q68551522 | ||
| High-intensity therapy versus low-intensity therapy in advanced breast cancer patients | Q68649691 | ||
| Survival in acute leukemia in elderly patients. No improvement in the 1980s | Q68768432 | ||
| Treatment of non-Hodgkin's lymphoma in the elderly | Q68917795 | ||
| Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial | Q69056842 | ||
| Choice of cancer therapy varies with age of patient | Q69520224 | ||
| Pharmacokinetic aspects of drug therapy in the elderly | Q69603137 | ||
| [Cytostatic polychemotherapy in the aged] | Q69806019 | ||
| Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia | Q69821144 | ||
| Advance directives for medical care--a case for greater use | Q70111595 | ||
| Needed: clinical trials for older patients | Q70139443 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 192-209 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Palliative therapies in elderly cancer patients | |
| P478 | volume | 6 |
| Q37357536 | Goals of care toward the end of life: a structured literature review. |
| Q50784629 | Good death study of elderly patients with terminal cancer in Taiwan. |
| Q40970106 | When drug treatment in the elderly is not cost effective. An ethical dilemma in an environment of healthcare rationing |
Search more.